EPICS Therapeutics Revenue and Competitors

Gosselies, BE

Location

$39M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • EPICS Therapeutics's estimated annual revenue is currently $5.4M per year.(i)
  • EPICS Therapeutics's estimated revenue per employee is $155,000
  • EPICS Therapeutics's total funding is $39M.

Employee Data

  • EPICS Therapeutics has 35 Employees.(i)
  • EPICS Therapeutics grew their employee count by 13% last year.

EPICS Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.6M17-6%$82.2MN/A
#2
$3.6M2353%$93.4MN/A
#3
$1.1M70%N/AN/A
#4
$5.4M3513%$38.9MN/A
#5
$5.1M3327%$16.4MN/A
#6
$17.4M11233%N/AN/A
#7
$5.1M2729%$66.1MN/A
Add Company

What Is EPICS Therapeutics?

EPICS is a drug discovery and development company that invents and develops small molecule drugs targeting RNA epigenetic mechanisms involved in cancer development. EPICS’s mission is to utilize its expertise in drug discovery and development to invent novel clinical agents targeting serious unmet medical needs in oncology. We develop products to meet high value-added endpoints. We constantly balance risk and reward in determining if and when to partner our programs.

keywords:N/A

$39M

Total Funding

35

Number of Employees

$5.4M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.3M3719%N/A
#2
$6M39-25%N/A
#3
$9.1M59-12%N/A
#4
$16.4M10628%N/A
#5
$18.1M11738%$83.7M